Michael B. Rothberg
机构:Cleveland Clinic, Cleveland Clinic Lerner College of Medicine · ORCID:0000-0002-2063-1876
发表论文 585 篇 · 总被引 16557 次 · h-index 64
代表论文
- Changes in weight and glycemic control following obesity treatment with semaglutide or tirzepatide by discontinuation status (2025 · Obesity · 被引 37)
- Reasons for Discontinuation of Obesity Pharmacotherapy With Semaglutide or Tirzepatide in Clinical Practice (2025 · Obesity · 被引 30)
- Macrovascular and microvascular outcomes of metabolic surgery versus GLP-1 receptor agonists in patients with diabetes and obesity (2025 · Nature Medicine · 被引 15)
- Value-Based Pricing of Resmetirom for Metabolic Dysfunction–Associated Steatotic Liver Disease (2025 · JAMA Network Open · 被引 13)
- Socio‐demographic and clinical factors associated with the receipt of anti‐obesity medication prescriptions and metabolic and bariatric surgery among eligible all of Us participants (2025 · Diabetes Obesity and Metabolism · 被引 12)
- Evaluating an artificial intelligence scribe for clinical documentation (2025 · Digital Health · 被引 8)